Viewing nowGabvilda tablet 50 milligrams (Vildagliptin)
Vildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.

MFDS item code 202102182 · Approved 2021.03.09 · Insurance code 625202140
Improvement of blood glucose control in type 2 diabetes
This medication is used in conjunction with diet and exercise therapy to help patients with type 2 diabetes control their blood sugar levels. It can be used alone or in combination with other medications to enhance therapeutic effects. This contributes to helping with blood sugar management, enabling a healthy daily life.
This medicine may be administered as monotherapy or in combination with metformin in patients who have not previously received drug therapy for diabetes, at 50mg once daily in the morning or 100mg daily as 50mg twice daily, divided between morning and evening. When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose when this medicine is used in combination with metformin or a thiazolidinedione is 100mg daily, as 50mg twice daily, divided between morning and evening. When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose when this medicine is used in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. When adequate glycemic control cannot be achieved with combination therapy with a sulfonylurea and metformin, the recommended dose when this medicine is added (as triple therapy) is 100mg daily, as 50mg twice daily, divided between morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is added is 100mg daily, as 50mg twice daily, divided between morning and evening. This medicine may be taken with or without food, and doses greater than 100mg daily are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the dose of the sulfonylurea may be needed to reduce the risk of hypoglycemia. If you miss a dose, take this medicine as soon as you remember, and take your next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting treatment. Patients with renal impairment Mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. Moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See Precautions, ‘3. General Precautions,’ item 2.)
This medication should not be used by patients who are allergic to the active ingredient or other components. This medication should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic issues such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. In clinical trials, most adverse reactions were mild and temporary, with no need to discontinue treatment. Liver function abnormalities, especially hepatitis, have been reported rarely but are usually asymptomatic and recover upon discontinuation of the medication. Angioedema may occur rarely, particularly when taken with ACE inhibitors, increasing its frequency. When this medication is used alongside other diabetes medications, caution is needed as hypoglycemic symptoms may arise. Particularly when combined with sulfonylureas, the risk of hypoglycemia may increase, requiring dosage adjustments. This medication does not replace insulin; patients who require insulin therapy must continue their insulin administration. Caution is advised in patients with very poor kidney function regarding the use of this medication. Regular liver function tests should be conducted, and if liver function markers significantly elevate, this medication should be discontinued. Use is not recommended in severe heart failure patients and caution is needed in mild to moderate cases. Abnormal symptoms such as blisters or ulcers may appear on the skin, so skin conditions should be monitored continuously. If acute pancreatitis symptoms arise, discontinue the medication immediately and seek medical attention. In case of symptoms such as dizziness, avoid driving or operating machinery. Severe arthralgia may occur, and if symptoms arise, discontinue use and consult with a healthcare provider. If skin conditions resembling bullous pemphigoid occur, consult a physician immediately, and discontinue the medication if necessary. Pregnant women should not use this medication, and breastfeeding women are also advised to avoid taking it. Elderly patients do not generally require dose adjustments, but this medication is not recommended for children and adolescents under 18, as safety and efficacy have not been established. There is no specific antidote for overdose; symptomatic support should be provided, and blood dialysis is ineffective at removing the medication. This medication should be stored out of reach of children, and transferring it to other containers should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.
Round tablets that are white to light yellow in color
30 tablets/box (10 tablets/Alu-Alu*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Ahn-Guk New Pharm Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.
Vildagliptin 50mg
Tablet · Prescription medication
Pharmgen Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.